Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

Delayed Data
As of Aug 18
 -0.44 / -1.54%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 57.00, with a high estimate of 94.00 and a low estimate of 39.00. The median estimate represents a +103.14% increase from the last price of 28.06.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 24.11%
Growthannually -117.62%


Growthquarterly 110.57%
Growthannually 66.66%
Key to the earnings and sales forecast charts.